Navigation Links
Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
Date:8/22/2007

MORRISTOWN, N.J., Aug. 22 /PRNewswire/ -. Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food & Drug Administration to market Fentanyl Transdermal System. Distribution of the product will begin immediately.

Fentanyl Transdermal System is the generic equivalent of Alza/Janssen's Duragesic(R) and available in 25, 50, 75 and 100 mcg/hour strengths. Fentanyl Transdermal System is indicated for the management of persistent, moderate to severe chronic pain that requires continuous, around the clock opioid administration for an extended period of time and cannot be managed by other means such as non-steroidal analgesics, opioid combination products or immediate release opioids.

Robert Wessman, President and CEO said:

"The approval of fentanyl transdermal system signifies an important milestone for Actavis. The addition of transdermal fentanyl is representative of our continued effort to expand the depth and breadth of our product portfolio, and highlights our product development expertise in specialty generic products."

Annual brand and generic sales of fentanyl transdermal system in the U.S. were approximately US$1.2 billion for the twelve months ending June 2007 according to IMS health data.

About Actavis

Actavis is one of the world's leading generic pharmaceutical companies specializing in the development, manufacture and sale of generic pharmaceuticals. With headquarters in Iceland, Actavis has operations in 39 countries, with 11,000 employees. Actavis expects 2007 sales to total EUR1.6bn, with approximately one-third of these sales coming from the United States, the company's single largest market. In the U.S. alone, the company made 38 ANDA filings in 2006 and expects to file 40-45 in the year 2007 along with 18-20 new product launches. The company's U.S. operations are located in New Jersey, Maryland, North Carolina and Florida.

More inform
'/>"/>

SOURCE Actavis Group
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Lucigen receives $750K grant to boost biofuel yields
3. Medical College receives $1.4M cancer grant
4. Wisconsin biotech firm receives $107K NIH grant
5. InvivoSciences receives NIH grant for heart technology
6. Medical College receives $11 million grant to study high blood pressure
7. Madison business receives $115,000 of new state biofuels funding
8. Superior receives funds for technical training
9. UWM receives state funding for plastics research
10. GEs Centricity EHR receives federal certification
11. WHIE receives state eHealth Initiative contract

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...ov. 19 Spherix Incorpora...y for diabetes therapy, and a provider of technica...lement, biotechnology and pharmaceutical companies...Meeting of Shareholders. ,, At the meeting, sha... elected the following members to the Board of Dir...
(Date:11/19/2009)...op LASIK surgeons and recognized refractive and ca...geons made brought their fellow surgeons up-to-dat...surgery, cataract surgery, and ophthalmology in ge...f Ophthalmology (AAO) annual meeting in San Franci...r Tauber, Dr. David Huang, MD, Dr. Randy Epstein, ...
(Date:11/18/2009)...v. 18 Marrone Bio Innovations (MBI...ercialization of effective and environmentally res...it has been named an IC20 company by the Investors...tional angel investing group. ,, Companies name...rding results for all stakeholders, including inve...
(Date:11/18/2009)...versity Belfast are developing new sensors to dete...lp in the fight against the threat of terrorist at...o ,swipe, an individual or crime scene to gather a...ument that can detect the presence of chemicals wi...ions to be made in response to terrorist threats. ...
Breaking Biology Technology:Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9Marrone Bio Innovations Named an IC20 Company 2New technology detects chemical weapons in seconds 2
...ETA, Calif., April 9 Copan Diagnostics, Inc. is p...: Walk-Away Specimen Processor in Canada at Vancou...cimen Processor is a revolutionary system for auto... The breakthrough technology behind the WASP, coup...ab system for automation, make the WASP the first ...
...EIJING, April 9 /PRNewswire-Asia/ -- Sinovac Biote...nd provider of vaccines in China, today announced,...three and twelve month,periods ended December 31, ... -- Record full year 2008 sales increasing 39% y...6.93 million doses of Healive(R) in 2008, up from ...
...O, Calif., April 9 BioMarin Pharmaceutical Inc. (... Bienaime, Chief Executive Officer of BioMarin, wi... April 30, at 5:00 p.m. ET (23:00 CET) to discuss ...S. / Canada Dial-in Number: 866.383.7998, Inte...ipant Code: 63957862, Replay Dial-in Number: 88...
Other Biology Technology:Vancouver General Hospital is the First Canadian Institution to Implement Copan WASP(R): Walk-Away Specimen Processor 2Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 2Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 3Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 4Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 5Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 6Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 7Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 8Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 9Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 10Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 11Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 12Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 13Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 14Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 15Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 16Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 17Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables 18BioMarin to Host First Quarter 2009 Financial Results Conference Call and Webcast on Thursday, April 30 at 5:00 p.m. ET (23:00 CET) 2
(Date:11/23/2009)...ble in German . , Of all global carbon diox...mosphere where it contributes to global warming. T...ial ecosystems such as forests, grasslands and pea...c and terrestrial ecosystems is considered one of ...limate change. However, new greenhouse gas bookkee...
(Date:11/22/2009)...ne deletion can increase the likelihood of immune ...n, an international team of researchers reports in...enetics . When the gene, called UGT2B17, is missin...ient,s, transplants have a significantly greater r...-host disease, in which immune cells from the dono...
(Date:11/21/2009)...ember 20,2009 / b3c newswire / - KINAXO Biotechn...ing round, gaining two new investors in the compan...AXO reports that Jrgen Schumacher has been elected..., KINAXO shareholders Axel Ullrich, Hellmut Kirch...utional investors Mountain Partners, BioM, High-Te...
Breaking Biology News(10 mins):Intensive land management leaves Europe without carbon sinks 2Gene mismatch influences success of bone marrow transplants 2Gene mismatch influences success of bone marrow transplants 3Gene mismatch influences success of bone marrow transplants 4KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3Houston Dermatologists to Round Up for Sun Safety at World Class LPGA Tour Championship 61451 1Houston Dermatologists to Round Up for Sun Safety at World Class LPGA Tour Championship 61451 2Ignite Institute Receives Support from Commonwealth of Virginia Fairfax County 24200 Million in Initial Funding and Financial Backing Locks in Key 61446 1Ignite Institute Receives Support from Commonwealth of Virginia Fairfax County 24200 Million in Initial Funding and Financial Backing Locks in Key 61446 2Ignite Institute Receives Support from Commonwealth of Virginia Fairfax County 24200 Million in Initial Funding and Financial Backing Locks in Key 61446 3Ignite Institute Receives Support from Commonwealth of Virginia Fairfax County 24200 Million in Initial Funding and Financial Backing Locks in Key 61446 4Ignite Institute Receives Support from Commonwealth of Virginia Fairfax County 24200 Million in Initial Funding and Financial Backing Locks in Key 61446 5Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 1Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 2Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 3Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 4Karmanos Cancer Institute Launches Company and Innovative Breast Imaging Tool 6302 5
...who ate fish at least once a week displayed higher...it ate it less frequently, according to a study of...ue of Acta Paediatrica . , Eating fish once a ...isuospatial intelligence scores by an average of s...ek increased them by just under 11 per cent. , Sw...
...ets of human DNA put scientists from the Universit... chromosome 8 occurs with significantly higher fr...n the control group. The results are to be publish... Genetics . , Cleft lips and palates are among th... 700 babies in Central Europe are affected. Childr...
...rsity of California, San Diego, offer a new explan... in of mammals found along the Malay Peninsula in ...ecies in the absence of any geographical barrier.... and the Andaman Sea was once thought have split t...s of animals to diverge. But a recent revision of ...
Other Biology News:Teenage boys who eat fish at least once a week achieve higher intelligence scores 2Teenage boys who eat fish at least once a week achieve higher intelligence scores 3Cleft lip and palate: Genes more important than thought? 2New explanation for a puzzling biological divide along the Malay Peninsula 2
Eco RII (Bst NI) from Roche Applied Science
...pe I eukaryotic topoisomerase that removes both po...d right- and left-handed supercoils) from covalent...valently closed, circular DNA with fewer positive ...I does not absolutely require Mg 2+ to function, ...
...ivity Kit TNF-α Converting Enzyme Activity K...AW CYCLES. The InnoZyme™ TACE Activity Kit i...re human TACE activity in cell lysates and biologi...n Anti-Human TACE-Coated 96-Well Plate is pre-coat...
...ains reagents required to perform a bisulfite modi...n, all unmethylated cytosines are deaminated and s...hylcytosines remain unaltered. Thus, the sequence ...r the DNA is originally methylated or unmethylated...
Biology Products: